Abstract
Background
In this study we analyzed gender differences in the clinical presentation of patients with molecular confirmed influenza A. Additionally, we tried to identify predictors of influenza-associated mortality.
Materials/methods
In this prospective observational multi-center-study we included all influenza-positive patients ≥ 18 years who were hospitalized and treated on flu-isolation-wards in three hospitals in Vienna during the 2018/19 influenza season. Diagnoses were made via Cobas® Liat® POCT.
Results
490 Patients (48.8% female) tested positive for influenza A. Female patients were older (median age 76 years vs. 70 years, p < 0.001). Male patients had a higher rate of chronic liver disease in history (8.8% vs. 2.9%, p = 0.006), myositis (11.7% vs. 3.1%, p < 0.001) and ICU admissions (9.6% vs. 4.6%, p = 0.03). The in-hospital mortality rate was 4.3% and increased to 9.5% during the 90-day follow-up period. Female patients > 75 years had a significantly higher in-hospital mortality rate than ≤ 75-year-old females (9.2% vs. 1.7%, p = 0.019). This effect was not observed in male patients (5.4% vs. 1.9%, p = ns). Age > 75 years (OR 5.49, 95% CI 1.10–27.43), acute heart failure (OR 3.56, 95% CI 1.03–12.05) and ICU admission (OR 6.1, 95% CI 0.98–37.91) were predictors for in-hospital mortality for female patients, while any malignancy (OR 9.4, 95% CI 1.90–46.54) and ICU admission (OR 7.05, 95% CI 1.44–34.55) were predictors in male patients.
Conclusions
Gender is associated with differences in clinical presentation and complications of influenza A virus infection. Women with acute heart failure or aged > 75 years have an increased risk of influenza associated in-hospital mortality, while ICU admission and any malignancy are predictors for male patients. Mortality rates in patients > 75 years are 5–10 times higher compared to their non-hospitalized influenza-negative Austrian counterparts.
Similar content being viewed by others
References
White A, Ironmonger L, Steele RJC, et al. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer. 2018;18:906. https://doi.org/10.1186/s12885-018-4786-7.
Bots SH, Peters SAE, Woodward M. Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010. BMJ Global Health. 2017;2:e000298. https://doi.org/10.1136/bmjgh-2017-000298.
Seedat S, Scott KM, Angermeyer MC, et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry. 2009;66:785–95.
Fabbian F, De Giorgi A, Lopez-Soto PJ, et al. Is female gender as harmful as bacteria? Analysis of hospital admissions for urinary tract infections in elderly patients. J Womens Health (Larchmt). 2015;24:587–92.
Jensen-Fangel S, Mohey R, Johnsen SP, et al. Gender differences in hospitalization rates for respiratory tract infections in Danish youth. Scand J Infect Dis. 2004;36:31–6.
Gutiérrez F, Masiá M, Mirete C, et al. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect. 2006;53:166–74.
Klein SL, Pekosz A, Passaretti C, et al. Sex, gender and influenza. World Health Organization, Geneva, 2010, pp. 1–58
Eshima N, Tokumaru O, Hara S, et al. Sex- and age-related differences in morbidity rates of 2009 pandemic influenza A H1N1 virus of swine origin in Japan. PLoS ONE. 2011;6:e19409.
Quandelacy TM, Viboud C, Charu V, et al. Age- and sex-related risk factors for influenza-associated mortality in the United States between 1997–2007. Am J Epidemiol. 2014;1792:156–67.
Lee N, Choi KW, Chan PKS, et al. Outcomes of adults hospitalised with severe influenza. Thorax. 2010;65:510–5.
Topoulos S, Giesa C, Gatermann S, et al. Analysis of acute respiratory infections due to influenza A, B and RSV during an influenza epidemic 2019. Infection. 2019. https://doi.org/10.1007/s15010-018-1262-x.
Katzen J, Kohn R, Houk J, et al. Early oseltamivir after hospital admission is associated with shortened hospitalization: a five-year analysis of oseltamivir timing and clinical outcomes. Clin Infect Dis. 2019;69:52–8. https://doi.org/10.1093/cid/ciy860.
Pawelka E, Karolyi M, Daller S, et al. Influenza virus infection: an approach to identify predictors for in-hospital and 90-day mortality from patients in Vienna during the season 2017/18. Infection. 2019. https://doi.org/10.1007/s15010-019-01335-0.
Chung JY, Hsu CC, Chen JH, et al. Geriatric influenza death (GID) score: a new tool for predicting mortality in older people with influenza in the emergency department. Sci Rep. 2018;8:9312. https://doi.org/10.1038/s41598-018-27694-6.
Schmidt RLJ, Simon A, Popow-Kraupp T, et al. A novel PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of influenza virus infection. ClinMicrobiol Infect. 2019;25:1032–7. https://doi.org/10.1016/j.cmi.2018.12.017.
https://www.statistik.at/wcm/idc/idcplg?IdcService=GET_NATIVE_FILE&RevisionSelectionMethod=LatestReleased&dDocName=121430. Accessed 2 Apr
Klein SL, Hogson A, Robinson DP. Mechanisms of sex disparities in influenza pathogenesis. J LeukocBiol. 2012;92:67–73.
Ingersoll MA. Sex differences shape the response to infectious diseases. PLoSPathog. 2017;13:e1006688. https://doi.org/10.1371/journal.ppat.1006688.
Robinson DP, Lorenzo ME, Jian W, Klein SL. Elevated 17beta-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses. PLoSPathog. 2011;7:e1002149. https://doi.org/10.1371/journal.ppat.1002149 ((PMID: 21829352)).
Robinson DP, Hall OJ, Nilles TL, et al. 17beta-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs. J Virol. 2014;88:4711–20.
Hall OJ, Limjunyawong N, Vermillion MS, et al. Progesterone-based therapy protects against influenza by promoting lung repair and recovery in females. PLoSPathog. 2016;12:e1005840. https://doi.org/10.1371/journal.ppat.1005840 ((PMID: 27631986)).
Engler RJ, Nelson M, Klote MM, et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004–2005): age, dose, and sex effects on immune responses. Arch Intern Med. 2008;168:2405–14.
Cook IF, Barr I, Hartel G, et al. Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults. Vaccine. 2006;24:2395–402.
Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061.
Rossignol P, Hernandez AF, Solomon SD, et al. Heart failure drug treatment. Lancet. 2019;393:1034–44.
Modin D, Jørgensen ME, Gislason G, et al. Influenza vaccine in heart failure cumulative number of vaccinations, frequency, timing, and survival: a Danish Nationwide cohort study. Circulation. 2018;139:00–00. https://doi.org/10.1161/CIRCULATIONAHA.118.036788.
Fukuta H, Goto T, Wakami K, et al. The effect of influenza vaccination on mortality and hospitalization in patients with heart failure: a systematic review and meta-analysis. Heart Fail Rev. 2019;24:109–14. https://doi.org/10.1007/s10741-018-9736-6.
Funding
This study was not funded.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors do not have any conflicts of interest.
Rights and permissions
About this article
Cite this article
Karolyi, M., Pawelka, E., Kelani, H. et al. Gender differences and influenza-associated mortality in hospitalized influenza A patients during the 2018/19 season. Infection 49, 103–110 (2021). https://doi.org/10.1007/s15010-020-01537-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-020-01537-x